Martínez-Gómez María Amparo, Sagrado Salvador, Villanueva-Camañas Rosa María, Medina-Hernández Maria José
Departamento de Química Analítica, Facultat de Farmacia, Universitat de València, C/Vicent Andrés Estellés s/n, E-46100 Burjassot, Valencia, Spain.
Anal Chim Acta. 2007 Jan 23;582(2):223-8. doi: 10.1016/j.aca.2006.09.036. Epub 2006 Sep 26.
Nowadays, there is a special interest within the pharmaceutical laboratories to develop single enantiomer formulations and consequently a need for analytical methods to determine the enantiomeric purity of drugs. The present paper deals with the enantiomeric separation of promethazine and trimeprazine enantiomers by affinity electrokinetic chromatography (AEKC)-partial filling technique using human serum albumin (HSA) as chiral selector. A multivariate optimization of the most critical experimental variables in enantioresolution, running pH, HSA concentration and plug length, is carried out to obtain enantioresolution of promethazine and trimeprazine. The estimated maximum and optimum resolution of trimeprazine and prometazine enantiomers (Rs=1.74 and 2.01, respectively) corresponded to the following experimental conditions: pH 7.5; [HSA] 170 microM and plug length 190 s and pH 7.6; [HSA] 170 microM and plug length 170 s, for trimeprazine and prometazine, respectively. The developed methodologies were applied for the enantiomeric quality control of promethazine and trimeprazine enantiomers in commercially available pharmaceutical formulations. Resolution, accuracy, reproducibility, cost and sample throughput of the proposed methodologies make it suitable for quality control of the enantiomeric composition of promethazine and trimeprazine in pharmaceutical preparations.
如今,制药实验室对开发单一对映体制剂有着特殊兴趣,因此需要用于测定药物对映体纯度的分析方法。本文采用人血清白蛋白(HSA)作为手性选择剂,通过亲和毛细管电泳色谱法(AEKC)-部分填充技术对异丙嗪和曲美苄嗪对映体进行对映体分离。对映体拆分中最关键的实验变量,即运行pH值、HSA浓度和塞子长度进行多变量优化,以实现异丙嗪和曲美苄嗪的对映体拆分。曲美苄嗪和异丙嗪对映体的估计最大和最佳分离度(Rs分别为1.74和2.01)对应以下实验条件:曲美苄嗪为pH 7.5、[HSA] 170 microM和塞子长度190秒;异丙嗪为pH 7.6、[HSA] 170 microM和塞子长度170秒。所开发的方法应用于市售药物制剂中异丙嗪和曲美苄嗪对映体的对映体质量控制。所提出方法的分离度、准确性、重现性、成本和样品通量使其适用于药物制剂中异丙嗪和曲美苄嗪对映体组成的质量控制。